Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Safety and Tolerability Study of Crenolanib in Combination With Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients With FLT3 Mutations

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02283177
Recruitment Status : Completed
First Posted : November 5, 2014
Last Update Posted : July 20, 2020
Sponsor:
Information provided by (Responsible Party):
Arog Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2019
Actual Study Completion Date : December 2019